Preventive Effects of Penehyclidine Hydrochloride Inhalation on Postoperative Pulmonary Complications

PHASE4CompletedINTERVENTIONAL
Enrollment

864

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

November 8, 2018

Study Completion Date

December 10, 2018

Conditions
Postoperative Complications
Interventions
DRUG

Penehyclidine inhalation

Penehyclidine inhalation will be administered by inhalation (penehyclidine hydrochloride 0.5 mg/0.5 ml, mixed with normal saline 5.5 ml) once every 12 hours from the night before surgery till the second day after surgery. The total number of inhalation is seven times. Study drug inhalation is performed with the high-flow oxygen-driven method for the non-intubated patients or with the atomizing inhalation device of ventilator for the intubated patients.

DRUG

Placebo inhalation

Placebo inhalation will be administered by inhalation (water for injection 0.5 ml, mixed with normal saline 5.5 ml) once every 12 hours from the night before surgery till the second day after surgery. The total number of inhalation is seven times. Study drug inhalation is performed with the high-flow oxygen-driven method for the non-intubated patients or with the atomizing inhalation device of ventilator for the intubated patients.

Trial Locations (1)

100034

Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER

NCT02644876 - Preventive Effects of Penehyclidine Hydrochloride Inhalation on Postoperative Pulmonary Complications | Biotech Hunter | Biotech Hunter